Trial Information

Summary: Human C1 Esterase Inhibitor (C1-INH) in Subjects with congenital C1-INH Deficiency and Acute Abdominal or Facial HAE Attacks.

Condition: Hereditary Angioedema (HAE)

Study Description: The purpose of this study is to show that C1-INH concentrate ( an investigational product ) shortens the time to onset of relief of symptoms of abdominal or facial HAE attacks compared to placebo.

Patient Inclusion Criteria

You may be able to participate in this study if you:

• Have a diagnosis of hereditary C1-INH deficiency
• Have a documented history of facial or abdominal attacks
• Are 6 years of age or older

Patient Exclusion Criteria

You may not participate in this study if you:

• Have been treated with any C1-INH product within the previous 7 days
• Have been treated with any investigational drug within the last 30 days
• Are being treated with an ACE inhibitor

If you would like to learn more about participating in this study, please send an e-mail message using the form below.